The role of antihypertensive drugs in patients with preeclampsia and how to prevent it
Open Access
- 7 December 2022
- journal article
- research article
- Published by Universitas Airlangga in Majalah Obstetri & Ginekologi
- Vol. 30 (3) , 146-153
Abstract
HIGHLIGHTS 1. Preeclampsia, or hypertension in pregnancy, remains a serious problem that has negative short and long-term consequences for the mother and the baby. 2. The use of antihypertensive medications has its own precautions as it they may harm the fetus. 3. Prophylactic measures with minimal or moderate impact may be beneficial for mothers with hypertension in pregnancy. ABSTRACT Treatment of hypertension in pregnancy, such as preeclampsia (PE), is still a difficult issue with negative short and long-term consequences for both the mother and the baby. Screening for preeclampsia at 11-13 weeks' gestation using a combination of maternal demographic characteristics and medical history with biomarker measurements can identify approximately 75% of women who develop premature preeclampsia with delivery at 37 weeks gestation and 90% of those with early preeclampsia. Preeclampsia has a 10% positive screen rate at 32 weeks. Another important worry on the use of antihypertensive medications during pregnancy is the potential harm to the fetus. Methyldopa, hydralazine, labetalol, and nifedipine are some common antihypertensive medications. Aspirin use is frequently related to a decrease in the prevention of early preeclampsia, but it must be accompanied by medication adherence. Aspirin can be coupled with heparin. Recent investigations on the use of furosemide and nifedipine in preeclampsia have also revealed a new combination.Keywords
This publication has 36 references indexed in Scilit:
- The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practicePregnancy Hypertension, 2018
- Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unitAmerican Journal of Obstetrics and Gynecology, 2018
- Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2017
- An analysis of the differences between early and late preeclampsia with severe hypertensionPregnancy Hypertension, 2016
- A systematic review of nicardipine vs labetalol for the management of hypertensive crisesThe American Journal of Emergency Medicine, 2012
- Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopaArchives of Gynecology and Obstetrics, 2012
- Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2005
- Drugs for treatment of very high blood pressure during pregnancy2002
- Contemporary Concepts of the Pathogenesis and Management of PreeclampsiaJAMA, 2002
- Practice bulletin #33: diagnosis and management of preeclampsia and eclampsiaObstetrics & Gynecology, 2002